{"id":56294,"date":"2023-04-27T15:06:50","date_gmt":"2023-04-27T13:06:50","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/ntx-expands-commercial-and-operational-teams-to-accelerate-growth\/"},"modified":"2023-04-27T15:06:50","modified_gmt":"2023-04-27T13:06:50","slug":"ntx-expands-commercial-and-operational-teams-to-accelerate-growth","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/ntx-expands-commercial-and-operational-teams-to-accelerate-growth\/","title":{"rendered":"NTx Expands Commercial and Operational Teams to Accelerate Growth"},"content":{"rendered":"
\n

\nNew CCO, VP of IT Infrastructure and Operations, and Sr. Director of Customer Excellence with experience from Dell, and IBM Healthcare and Life Sciences, join to advance NTx\u2019s commercial and operational capabilities<\/i><\/p>\n

RIO RANCHO, N.M.–(BUSINESS WIRE)–Nature’s Toolbox, Inc. (NTx)<\/a>, a life sciences company enabling novel pharmaceutical RNA and protein development and production, today announced the expansion of its team with the appointments of Sheila Moran as Chief Commercial Officer, Phillip Easton, Ph.D. as Vice President of IT Infrastructure and Operations, and Lily Pisani as Senior Director of Customer Excellence.<\/p>\n

<\/a>
<\/a><\/p>\n

\n\u201cNature\u2019s Toolbox is on the verge of a major commercialization push that will take our proprietary technology out of the lab and into the global market,\u201d said Jamie Coffin, Ph.D., CEO of NTx. \u201cI worked with Sheila, Phillip, and Lily prior to joining NTx, and know they all have the right skills and experience to ensure NTx is set up for commercial success, bring in new customers, and drive financial growth.\u201d<\/p>\n

\nSheila Moran, CCO,<\/b> brings over 30 years of sales and business development experience in the healthcare and life sciences industries to Nature\u2019s Toolbox. She most recently served as the Senior Vice President of Solution Sales at Sema4, where she led and directed sales, customer, and clinical support activities, including the establishment of commercial sales operations for the company\u2019s genomic testing and data business. She delivered double-digit growth every quarter for over three years achieving more than 300% growth in the testing footprint in women\u2019s health and oncology. Earlier in her career, she held leadership roles at Dell Healthcare and Life Sciences, and IBM Healthcare and Life Sciences.<\/p>\n

\n\u201cBiomanufacturing holds tremendous promise for the future of healthcare, as well as other industries. Nature\u2019s Toolbox is uniquely positioned to lead this transformation with its combination of cutting-edge science, molecular design, and engineering prowess,\u201d said Sheila Moran. \u201cMy background in technology and engineering within life sciences has prepared me for this exciting challenge of leading NTx into its commercialization phase alongside this amazingly talented team.\u201d<\/p>\n

\nPhillip Easton, Ph.D., VP of IT Infrastructure and Operations, <\/b>brings over 30 years of IT services and business development leadership experience to help implement NTx\u2019s IT strategy and operations. He most recently served as the Head of IT Services at Sema4, where he developed and implemented a company-wide IT strategy to support on-site and remote users and lab pipelines. During his time there, he was able to optimize resources and polices to realize $2M cost avoidance annually in technical expenses. Prior to Sema4, Phillip was a Business Development Manager at Dell Healthcare and Life Sciences where he developed solutions that resulted in $10 million in new hardware and software sales annually. Earlier in his career, he also worked in technical solutions for IBM Healthcare and Life Sciences.<\/p>\n

\nLily Pisani, Sr. Director of Customer Excellence,<\/b> will oversee NTx\u2019s sales and marketing strategies. She also comes to Nature\u2019s Toolbox from Sema4, where she began as a Marketing Manager specializing in events. She worked her way up to the role of REI Regional Business Director, NY and NJ <\/i><\/b>for the company\u2019s women\u2019s health portfolio, successfully maintaining and growing the second largest sales number in the country across all divisions. Lily has a proven track record of expanding startups\u2019 brand recognition and has been recognized throughout her career for her ability to develop and execute effective sales and marketing campaigns, build strong relationships with customers, and drive revenue growth. Prior to Sema4, Lily held various marketing roles at CooperSurgical where she organized and executed customer events and managed logistics for CooperSurgical\u2019s global tradeshow presence.<\/p>\n

\nFor more information about NTx and its proprietary platform, please visit: https:\/\/www.ntxbio.com<\/a>.<\/p>\n

\nAbout NTx
\n
<\/b>Nature’s Toolbox, Inc. (NTx) is a life sciences company located in Rio Rancho, New Mexico. The company is commercializing its biomanufacturing systems NTxpress\u00ae, NTxscribe\u00ae and the bioinformatics platform, DruID, for the discovery of natural products. NTx\u2019s proprietary continuous-flow, fully recombinant, in vitro, cell-free transcription system utilizes hollow fiber bioreactors to support the growing demand for mRNA-based vaccines and therapeutics. NTx\u2019s biomanufacturing processes can easily be scaled to meet fluctuating supply needs so that companies can increase and streamline production as they respond to changing global demands. For more information, please visit: https:\/\/www.ntxbio.com<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia<\/b>
Kalyn Kolek, kos@anzupartners.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

New CCO, VP of IT Infrastructure and Operations, and Sr. Director of Customer Excellence with experience from Dell, and IBM Healthcare and Life Sciences, join to advance NTx\u2019s commercial and operational capabilities RIO RANCHO, N.M.–(BUSINESS WIRE)–Nature’s Toolbox, Inc. (NTx), a life sciences company enabling novel pharmaceutical RNA and protein development and production, today announced the … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-56294","6":"format-standard","7":"category-industry"},"yoast_head":"\nNTx Expands Commercial and Operational Teams to Accelerate Growth - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/ntx-expands-commercial-and-operational-teams-to-accelerate-growth\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NTx Expands Commercial and Operational Teams to Accelerate Growth - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"New CCO, VP of IT Infrastructure and Operations, and Sr. Director of Customer Excellence with experience from Dell, and IBM Healthcare and Life Sciences, join to advance NTx\u2019s commercial and operational capabilities RIO RANCHO, N.M.–(BUSINESS WIRE)–Nature’s Toolbox, Inc. (NTx), a life sciences company enabling novel pharmaceutical RNA and protein development and production, today announced the ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/ntx-expands-commercial-and-operational-teams-to-accelerate-growth\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-27T13:06:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230427005170\/en\/1775968\/21\/NTX_Team_Expansion.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ntx-expands-commercial-and-operational-teams-to-accelerate-growth\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ntx-expands-commercial-and-operational-teams-to-accelerate-growth\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"NTx Expands Commercial and Operational Teams to Accelerate Growth\",\"datePublished\":\"2023-04-27T13:06:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ntx-expands-commercial-and-operational-teams-to-accelerate-growth\\\/\"},\"wordCount\":739,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ntx-expands-commercial-and-operational-teams-to-accelerate-growth\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230427005170\\\/en\\\/1775968\\\/21\\\/NTX_Team_Expansion.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ntx-expands-commercial-and-operational-teams-to-accelerate-growth\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ntx-expands-commercial-and-operational-teams-to-accelerate-growth\\\/\",\"name\":\"NTx Expands Commercial and Operational Teams to Accelerate Growth - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ntx-expands-commercial-and-operational-teams-to-accelerate-growth\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ntx-expands-commercial-and-operational-teams-to-accelerate-growth\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230427005170\\\/en\\\/1775968\\\/21\\\/NTX_Team_Expansion.jpg\",\"datePublished\":\"2023-04-27T13:06:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ntx-expands-commercial-and-operational-teams-to-accelerate-growth\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ntx-expands-commercial-and-operational-teams-to-accelerate-growth\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ntx-expands-commercial-and-operational-teams-to-accelerate-growth\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230427005170\\\/en\\\/1775968\\\/21\\\/NTX_Team_Expansion.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230427005170\\\/en\\\/1775968\\\/21\\\/NTX_Team_Expansion.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ntx-expands-commercial-and-operational-teams-to-accelerate-growth\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NTx Expands Commercial and Operational Teams to Accelerate Growth\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NTx Expands Commercial and Operational Teams to Accelerate Growth - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/ntx-expands-commercial-and-operational-teams-to-accelerate-growth\/","og_locale":"en_US","og_type":"article","og_title":"NTx Expands Commercial and Operational Teams to Accelerate Growth - Pharma Trend","og_description":"New CCO, VP of IT Infrastructure and Operations, and Sr. Director of Customer Excellence with experience from Dell, and IBM Healthcare and Life Sciences, join to advance NTx\u2019s commercial and operational capabilities RIO RANCHO, N.M.–(BUSINESS WIRE)–Nature’s Toolbox, Inc. (NTx), a life sciences company enabling novel pharmaceutical RNA and protein development and production, today announced the ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/ntx-expands-commercial-and-operational-teams-to-accelerate-growth\/","og_site_name":"Pharma Trend","article_published_time":"2023-04-27T13:06:50+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230427005170\/en\/1775968\/21\/NTX_Team_Expansion.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/ntx-expands-commercial-and-operational-teams-to-accelerate-growth\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/ntx-expands-commercial-and-operational-teams-to-accelerate-growth\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"NTx Expands Commercial and Operational Teams to Accelerate Growth","datePublished":"2023-04-27T13:06:50+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ntx-expands-commercial-and-operational-teams-to-accelerate-growth\/"},"wordCount":739,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/ntx-expands-commercial-and-operational-teams-to-accelerate-growth\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230427005170\/en\/1775968\/21\/NTX_Team_Expansion.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/ntx-expands-commercial-and-operational-teams-to-accelerate-growth\/","url":"https:\/\/pharma-trend.com\/en\/ntx-expands-commercial-and-operational-teams-to-accelerate-growth\/","name":"NTx Expands Commercial and Operational Teams to Accelerate Growth - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ntx-expands-commercial-and-operational-teams-to-accelerate-growth\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/ntx-expands-commercial-and-operational-teams-to-accelerate-growth\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230427005170\/en\/1775968\/21\/NTX_Team_Expansion.jpg","datePublished":"2023-04-27T13:06:50+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/ntx-expands-commercial-and-operational-teams-to-accelerate-growth\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/ntx-expands-commercial-and-operational-teams-to-accelerate-growth\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/ntx-expands-commercial-and-operational-teams-to-accelerate-growth\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230427005170\/en\/1775968\/21\/NTX_Team_Expansion.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230427005170\/en\/1775968\/21\/NTX_Team_Expansion.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/ntx-expands-commercial-and-operational-teams-to-accelerate-growth\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"NTx Expands Commercial and Operational Teams to Accelerate Growth"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56294","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=56294"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56294\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=56294"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=56294"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=56294"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}